BBHC
CLB icon

Brown Brothers Harriman & Co’s Core Laboratories CLB Stock Holding History

Brown Brothers Harriman & Co’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-108
Closed -$3K – 1118
2020
Q4 		$3K Buy
108
+33
+44% +$674 ﹤0.01% 987
2020
Q3 		$1K Hold
75
– – ﹤0.01% 920
2020
Q2 		$2K Sell
75
-75
-50% -$1.34K ﹤0.01% 880
2020
Q1 		$2K Buy
150
+39
+35% +$1.09K ﹤0.01% 914
2019
Q4 		$4K Buy
111
+6
+6% +$270 ﹤0.01% 990
2019
Q3 		$5K Buy
+105
New +$4.88K ﹤0.01% 981
2018
Q3 		– Sell
-94
Closed -$12K – 826
2018
Q2 		$12K Buy
+94
New +$11.4K ﹤0.01% 641
2018
Q1 		– Sell
-20
Closed -$2K – 858
2017
Q4 		$2K Buy
+20
New +$2K ﹤0.01% 1028
2017
Q1 		– Sell
-744
Closed -$89K – 815
2016
Q4 		$89K Buy
744
+634
+576% +$70.2K ﹤0.01% 409
2016
Q3 		$12K Sell
110
-2,372
-96% -$273K ﹤0.01% 602
2016
Q2 		$307K Buy
2,482
+2,372
+2,156% +$286K ﹤0.01% 270
2016
Q1 		$12K Hold
110
– – ﹤0.01% 554
2015
Q4 		$12K Hold
110
– – ﹤0.01% 604
2015
Q3 		$11K Hold
110
– – ﹤0.01% 665
2015
Q2 		$13K Hold
110
– – ﹤0.01% 628
2015
Q1 		$11K Sell
110
-187
-63% -$19.9K ﹤0.01% 644
2014
Q4 		$36K Buy
297
+179
+152% +$23.5K ﹤0.01% 562
2014
Q3 		$17K Hold
118
– – ﹤0.01% 634
2014
Q2 		$20K Sell
118
-100
-46% -$17.8K ﹤0.01% 607
2014
Q1 		$43K Sell
218
-3,102
-93% -$586K ﹤0.01% 516
2013
Q4 		$634K Buy
3,320
+1,759
+113% +$327K ﹤0.01% 282
2013
Q3 		$264K Buy
1,561
+86
+6% +$13.3K ﹤0.01% 295
2013
Q2 		$224K Buy
+1,475
New +$209K ﹤0.01% 371

Other funds holding CLB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $4.29B AUM 4.26% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Brown Brothers Harriman & Co's CLB Position: Q1 2021 in Review

Brown Brothers Harriman & Co sold out of Core Laboratories (CLB) in Q1 2021, closing a stake of 108 shares — an estimated $3K sold.

Brown Brothers Harriman & Co first reported a position in CLB in Q2 2013 and held it in 23 quarters. The position peaked at $634K in Q4 2013. 183 funds tracked by Wall St. Rank hold CLB as of Q1 2021.

  • Brown Brothers Harriman & Co reported no remaining Core Laboratories position as of Q1 2021 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 108 Core Laboratories shares in Q1 2021, an estimated $3K.
  • Brown Brothers Harriman & Co first reported a position in Core Laboratories in Q2 2013 and held it in 23 quarters.
  • Brown Brothers Harriman & Co's Core Laboratories position peaked at $634K in Q4 2013.
  • 183 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2021.

Based on Brown Brothers Harriman & Co's 13F filing for Q1 2021, filed 13 May 2021.